A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
| Status: | Completed |
|---|---|
| Conditions: | Allergy, Ocular |
| Therapuetic Areas: | Ophthalmology, Otolaryngology |
| Healthy: | No |
| Age Range: | 10 - Any |
| Updated: | 10/12/2017 |
| Start Date: | September 2012 |
| End Date: | November 2012 |
A Single-Center, Double-Masked, Randomization, Vehicle-Controlled, Evaluation of the Onset and Duration of Action of AC-170 0.24% Ophthalmic Solution (Formula AFH-002) Compared to Vehicle (Formula AFH-001) in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis
The purpose of this study is to evaluate the onset and duration of action of AC-170 0.24%
compared to vehicle in the prevention of the signs and symptoms of allergic conjunctivitis in
the conjunctival allergen challenge (CAC) model.
compared to vehicle in the prevention of the signs and symptoms of allergic conjunctivitis in
the conjunctival allergen challenge (CAC) model.
Inclusion Criteria:
- positive bilateral conjunctival allergen challenge (CAC)reaction
Exclusion Criteria:
- known contraindications or sensitivities to the study medication or its components
- any ocular condition that, in the opinion of the investigator, could affect the
subjects safety trial parameters
- use of disallowed medication during the period indicated prior to the enrollment or
during the study
We found this trial at
1
site
Click here to add this to my saved trials
